메뉴 건너뛰기
Blood
Volumn 116, Issue 10, 2010, Pages 1630-1632
Sialic acid-IVIg targeting CD22
Author keywords

[No Author keywords available]
Indexed keywords

EID: 77956579955     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-06-289892     Document Type: Note
Times cited : (12)
References (10)
  • 1
    • 77956566546 scopus 로고    scopus 로고
    • IVIg modulates BCR-signaling through CD22 and promotes apoptosis in mature human B lymphocytes
    • Séïté JF, Cornec D, Renaudineau Y, Youinou P, Mageed RA, Hillion S. IVIg modulates BCR-signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood. 2010;116(10):1698-1704.
    • (2010) Blood , vol.116 , Issue.10 , pp. 1698-1704
    • Séïté, J.F.1    Cornec, D.2    Renaudineau, Y.3    Youinou, P.4    Mageed, R.A.5    Hillion, S.6
  • 2
  • 3
    • 72149102130 scopus 로고    scopus 로고
    • Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation
    • Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol. 2009;158(suppl 1):43-50.
    • (2009) Clin Exp Immunol , vol.158 , Issue.SUPPL. 1 , pp. 43-50
    • Schwartz-Albiez, R.1    Monteiro, R.C.2    Rodriguez, M.3    Binder, C.J.4    Shoenfeld, Y.5
  • 4
    • 42649089750 scopus 로고    scopus 로고
    • Anti-inflammatory actions of intravenous immunoglobulin
    • Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol. 2008;26:513-533.
    • (2008) Annu Rev Immunol , vol.26 , pp. 513-533
    • Nimmerjahn, F.1    Ravetch, J.V.2
  • 5
    • 29944444643 scopus 로고    scopus 로고
    • Toward molecular targeting with specific intravenous immunoglobulin preparation
    • Blank M, Nur I, Toub O, Maor A, Shoenfeld Y. Toward molecular targeting with specific intravenous immunoglobulin preparation. Clin Rev Allergy Immunol. 2005;29(3):213-217.
    • (2005) Clin Rev Allergy Immunol , vol.29 , Issue.3 , pp. 213-217
    • Blank, M.1    Nur, I.2    Toub, O.3    Maor, A.4    Shoenfeld, Y.5
  • 6
    • 39849095842 scopus 로고    scopus 로고
    • A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis
    • Fuchs S, Feferman T, Meidler R, et al. A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis. J Neuroimmunol. 2008;194(1-2):89-96.
    • (2008) J Neuroimmunol , vol.194 , Issue.1-2 , pp. 89-96
    • Fuchs, S.1    Feferman, T.2    Meidler, R.3
  • 7
    • 58149378347 scopus 로고    scopus 로고
    • Identification of a receptor required for the anti-inflammatory activity of IVIG
    • Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad SciU S A. 2008;105(50):19571-19578.
    • (2008) Proc Natl Acad SciU S A , vol.105 , Issue.50 , pp. 19571-19578
    • Anthony, R.M.1    Wermeling, F.2    Karlsson, M.C.3    Ravetch, J.V.4
  • 9
    • 1842555507 scopus 로고    scopus 로고
    • IVIG for autoimmune, fibrosis, and malignant conditions: Our experience with 200 patients
    • DOI 10.1023/B:JOCI.0000019809.55787.ec
    • Shoenfeld Y, Krause I. IVIG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients. J Clin Immunol. 2004;24(2):107-114. (Pubitemid 38457224)
    • (2004) Journal of Clinical Immunology , vol.24 , Issue.2 , pp. 107-114
    • Shoenfeld, Y.1    Krause, I.2
  • 10
    • 0021271330 scopus 로고
    • Use of intravenous immunoglobulin in chronic lymphocytic leukemia
    • Besa EC. Use of intravenous immunoglobulin in chronic lymphocytic leukemia. Am J Med. 1984;76(3A):209-218. (Pubitemid 14126175)
    • (1984) American Journal of Medicine , vol.76 , Issue.3 A , pp. 209-218
    • Besa, E.C.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.